Moderna said the Food and Drug Administration will need more time to complete its assessment of the biotech company’s Covid-19 vaccine for children ages 12 to 17.
The agency is looking specifically … [+733 chars]
Moderna says FDA needs more time to review its Covid vaccine for teens – CNBC